Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D3) [1]

I. Molnár, N. Stark, J. Lovato, B. L. Powell, J. Cruz, D. D. Hurd, J. S. Mathieu, T. C. Chen, M. F. Holick, S. Cambra, R. P. McQuellon, G. G. Schwartz

Research output: Contribution to journalLetter

6 Scopus citations
Original languageEnglish (US)
Pages (from-to)1089-1092
Number of pages4
JournalLeukemia
Volume21
Issue number5
DOIs
StatePublished - May 2007

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Molnár, I., Stark, N., Lovato, J., Powell, B. L., Cruz, J., Hurd, D. D., Mathieu, J. S., Chen, T. C., Holick, M. F., Cambra, S., McQuellon, R. P., & Schwartz, G. G. (2007). Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D3) [1]. Leukemia, 21(5), 1089-1092. https://doi.org/10.1038/sj.leu.2404601